NOVEL USE OF IL-1β COMPOUNDS
PROBLEM TO BE SOLVED: To provide novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SOLUTION: The invention discloses novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-in...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
24.11.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | PROBLEM TO BE SOLVED: To provide novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SOLUTION: The invention discloses novel use of IL-1β-ligand/IL-1 receptor disrupting compounds in the treatment and/or prevention of auto-inflammatory syndromes.SELECTED DRAWING: None
【課題】 自己炎症性症候群の処置および/または予防における、IL−1β−リガンド/IL−1受容体かく乱化合物の新規使用を提供すること。【解決手段】 自己炎症性症候群の処置および/または予防における、IL−1β−リガンド/IL−1受容体かく乱化合物の新規使用を見いだした。【選択図】なし |
---|---|
Bibliography: | Application Number: JP20170151327 |